1 例安罗替尼致患者甲状腺功能减退危象的临床诊疗分析

张玲, 韩佳君, 于丽

PDF(1699 KB)
抗感染药学 ›› 2023, Vol. 20 ›› Issue (11) : 1136-1140. DOI: 10.13493/j.issn.1672-7878.2023.11-005
药物不良反应

1 例安罗替尼致患者甲状腺功能减退危象的临床诊疗分析

    {{javascript:window.custom_author_cn_index=0;}}
  • {{article.zuoZhe_CN}}
作者信息 +

Analysis of Clinical Diagnosis and Treatment of One Patient with Hypothyroidism Crisis Caused by Anlotinib

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

本文亮点

{{article.keyPoints_cn}}

HeighLight

{{article.keyPoints_en}}

摘要

{{article.zhaiyao_cn}}

Abstract

{{article.zhaiyao_en}}

关键词

Key words

引用本文

导出引用
{{article.zuoZheCn_L}}. {{article.title_cn}}. {{journal.qiKanMingCheng_CN}}. 2023, 20(11): 1136-1140 https://doi.org/10.13493/j.issn.1672-7878.2023.11-005
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2023, 20(11): 1136-1140 https://doi.org/10.13493/j.issn.1672-7878.2023.11-005

参考文献

参考文献

{{article.reference}}

基金

版权

{{article.copyrightStatement_cn}}
{{article.copyrightLicense_cn}}
PDF(1699 KB)

Accesses

Citation

Detail

段落导航
相关文章

/